Tuberculosis Infection Clinical Trial
Official title:
Evaluation of TB-antigen Responsive T Cell Markers in Diagnosis of Tuberculosis and Extrapulmonary Tuberculosis
Diagnosis of active and latent pulmonary tuberculosis, as well as extrapulmonary tuberculosis, is still a major challenge of TB control in China. This observational study aims to evaluate TB-antigen responsive T cell markers in the diagnosis of tuberculosis and extrapulmonary tuberculosis and try to find new prompt and cost-effective laboratory tests for active TB screening.
The enrolled patients will be grouped into active or latent tuberculosis according to the bacteriological evidence of TB. The TB-antigen responsive T cell markers will be examined. The performance of each T cell marker for the diagnosis of active TB will be systematically evaluated. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04271397 -
Immunological Biomarkers in Tuberculosis Management
|
N/A | |
| Completed |
NCT04545164 -
Computer Aided Screening for Tuberculosis in Low Resource Environments
|
N/A | |
| Recruiting |
NCT05766267 -
Short-course Regimens for the Treatment of Pulmonary Tuberculosis
|
Phase 2/Phase 3 | |
| Recruiting |
NCT05756582 -
Prevalence of Latent Tuberculosis Infection in Health-care Workers and Students
|
||
| Enrolling by invitation |
NCT04988984 -
Development of Automated Molecular Diagnostic Platform for Tuberculosis Diagnosis (New Assay TB)
|
||
| Recruiting |
NCT01689831 -
Dose Study of Tuberculin Purified Protein Derivative (JHP/Dose)
|
Phase 2 | |
| Completed |
NCT05945498 -
Evaluation of ТВ/Flu-05Е Vaccine for the Prevention of Tuberculosis Infection in BCG-vaccinated Volunteers Aged 18-50 Years
|
Phase 1 | |
| Not yet recruiting |
NCT06352970 -
Effects of Tuberculosis Infection on Development and Function of the Placenta
|
||
| Recruiting |
NCT04575519 -
Adjunctive Acetylsalicylic Acid and Ibuprofen for Tuberculosis
|
Phase 2 | |
| Recruiting |
NCT05413551 -
Point-of-care Pharmacogenomic Testing to Optimize Isoniazid Dosing for Tuberculosis Prevention
|
Phase 1 | |
| Recruiting |
NCT03941210 -
Micro RNA as Prediction and/or Prognostic Markers of IRIS in TB-HIV Co-infected Patients
|
||
| Completed |
NCT04494516 -
Qualitative Understanding of Community TB Services Pre and Post the CHIP-TB Trial
|
||
| Withdrawn |
NCT03265977 -
A Phase II Study of H56:IC31 in Healthy Adolescents
|
Phase 2 | |
| Recruiting |
NCT05069688 -
Dolutegravir Pharmacokinetics Among HIV/TB Coinfected Children Receiving Standard and High-dose Rifampicin
|
Phase 1 | |
| Suspended |
NCT05330884 -
BCG Revaccination in Children and Adolescents
|
Phase 3 | |
| Recruiting |
NCT05342064 -
Closing -TB GAPs - for People Living With HIV: TB Guidance for Adaptable Patient-Centered Service
|
N/A | |
| Recruiting |
NCT05236452 -
Effect of Integrating Traditional Tuberculosis Care With Modern Health Care on Case Detection
|
N/A | |
| Recruiting |
NCT05443178 -
Safety and Tolerability of Chlorquine in Addition to Anti-tuberculosis Therapy
|
Phase 1 | |
| Recruiting |
NCT05122026 -
Safety and Tolerability of 1 Month Daily (1HP) and 3 Months Weekly (3HP) Isoniazid and Rifapentine With Pharmacokinetics of Dolutegravir (DTG) in Pregnant People With HIV
|
Phase 1/Phase 2 | |
| Recruiting |
NCT06221488 -
Testing Health Workers At Risk to Advance Our Understanding of TB Infection
|